Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma-1

Abstract

Els were negative correlated with the levels of RhoA protein in HCC with adjusted -0.447 and two-tailed probability, n = 53, = 0.01.<p><b>Copyright information:</b></p><p>Taken from "Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma"</p><p>http://www.biomedcentral.com/1471-2407/8/205</p><p>BMC Cancer 2008;8():205-205.</p><p>Published online 23 Jul 2008</p><p>PMCID:PMC2496915.</p><p></p

    Similar works

    Full text

    thumbnail-image

    Available Versions